Alector (ALEC) Short-term Investments (2018 - 2026)
Alector (ALEC) reported Short-term Investments of $129.6 million for Q1 2026, down 59.08% year-over-year from $316.6 million in Q1 2025, and down 31.89% quarter-over-quarter from $190.2 million in Q4 2025.
Alector (ALEC) Short-term Investments (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Short-term Investments data on file, last reported at $129.6 million in Q1 2026.
- Short-term Investments for Q1 2026 came in at $129.6 million, down 59.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $129.6 million (down 59.08% YoY), and the FY2025 annual result was $190.2 million, down 49.99% from the prior year.
- Short-term Investments declined to $129.6 million in Q1 2026 per ALEC's latest filing, from $190.2 million in the prior quarter.
- Over five years, Short-term Investments peaked at $636.6 million in Q2 2022 and troughed at $129.6 million in Q1 2026.
- A 5-year average of $410.3 million and a median of $455.8 million in 2024 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2022 and 2026: Short-term Investments jumped 228.38% in 2022, then slumped 59.08% in 2026.
- A 5-year view of Short-term Investments shows it stood at $558.5 million in 2022, then dropped by 15.08% to $474.3 million in 2023, then fell by 19.8% to $380.4 million in 2024, then sank by 49.99% to $190.2 million in 2025, then tumbled by 31.89% to $129.6 million in 2026.
- Business Quant data shows ALEC's Short-term Investments at $129.6 million in Q1 2026, $190.2 million in Q4 2025, and $214.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.55 Mn |
| Dec 31, 2025 | 190.22 Mn |
| Sep 30, 2025 | 214.61 Mn |
| Jun 30, 2025 | 262.51 Mn |
| Mar 31, 2025 | 316.58 Mn |
| Dec 31, 2024 | 380.38 Mn |
| Sep 30, 2024 | 420.04 Mn |
| Jun 30, 2024 | 455.79 Mn |
| Mar 31, 2024 | 489.53 Mn |
| Dec 31, 2023 | 474.31 Mn |
| Sep 30, 2023 | 486.90 Mn |
| Jun 30, 2023 | 498.51 Mn |
| Mar 31, 2023 | 473.77 Mn |
| Dec 31, 2022 | 558.53 Mn |
| Sep 30, 2022 | 574.08 Mn |
| Jun 30, 2022 | 636.59 Mn |
| Mar 31, 2022 | 413.95 Mn |
| Dec 31, 2021 | 406.10 Mn |
| Sep 30, 2021 | 261.32 Mn |
| Jun 30, 2021 | 193.86 Mn |